Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study-Reference-Cited by-同舟云学术

Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study

Published:2023-10 Issue: Volume:64 Page:102225
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Wan Eric Yuk Fai^ORCID,Yan Vincent Ka Chun,Wong Zoey Cho Ting,Chui Celine Sze Ling,Lai Francisco Tsz Tsun^ORCID,Li Xue,Wong Carlos King Ho^ORCID,Hung Ivan Fan Ngai,Lau Chak Sing,Wong Ian Chi Kei,Chan Esther Wai Yin^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022

2. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;N Engl J Med,2022

3. Therapeutic management of nonhospitalized adults with COVID-19,2023

4. Effectiveness of COVID-19 treatment with nirmatrelvir–ritonavir or molnupiravir among U.S. veterans: target trial emulation studies with one-month and six-month outcomes;Bajema;Ann Intern Med,2023

5. Effectiveness of molnupiravir and nirmatrelvir–ritonavir in hospitalized patients with COVID-19: a target trial emulation study;Wan;Ann Intern Med,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir;Infectious Diseases and Therapy;2024-06-03

2. Updated Bivalent COVID-19 Vaccines Reduce Risk of Hospitalization and Severe Outcomes in Adults: An Observational Cohort Study;Journal of Clinical Medicine Research;2024-05